CEA of SGLT2 Inhibitors in Gout Flares and Related ED Visits, Hospitalizations
In patients with gout, initiation of treatment with sodium–glucose cotransporter-2 inhibitors (SGLT2is) for diabetes may reduce recurrent flares; reduce gout-primary emergency department (ED) visits and hospitalizations;